{"id":"https://openalex.org/W7223085277","doi":"https://doi.org/10.1016/j.jacadv.2026.103201","title":"Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis","display_name":"Gender and Racial Distribution of Transthyretin Stabilizer Therapy in Patients With Transthyretin Cardiac Amyloidosis","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223085277","doi":"https://doi.org/10.1016/j.jacadv.2026.103201","pmid":"https://pubmed.ncbi.nlm.nih.gov/42910804","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13699705"},"language":"en","primary_location":{"id":"doi:10.1016/j.jacadv.2026.103201","doi":"https://doi.org/10.1016/j.jacadv.2026.103201","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103201","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103201?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103201?download=true","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159169835","display_name":"Stephen J. Foley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]},{"id":"https://openalex.org/I4210162397","display_name":"UMass Memorial Medical Center","ror":"https://ror.org/053v00853","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1303243448","https://openalex.org/I166722992","https://openalex.org/I4210162397"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Stephen J. Foley","raw_affiliation_strings":["University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Electronic address: Stephen.foley@umassmemorial.org"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Electronic address: Stephen.foley@umassmemorial.org","institution_ids":["https://openalex.org/I166722992","https://openalex.org/I4210162397"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5159202961","display_name":"Shruti Hegde","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I166722992","display_name":"University of Massachusetts Chan Medical School","ror":"https://ror.org/0464eyp60","country_code":"US","type":"education","lineage":["https://openalex.org/I166722992"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shruti Hegde","raw_affiliation_strings":["University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA","institution_ids":["https://openalex.org/I166722992"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5159169835"],"corresponding_institution_ids":["https://openalex.org/I166722992","https://openalex.org/I4210162397"],"apc_list":{"value":2936,"currency":"USD","value_usd":2936},"apc_paid":{"value":2936,"currency":"USD","value_usd":2936},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.81467391,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"5","issue":"10","first_page":"103201","last_page":"103201"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10217","display_name":"Cardiac electrophysiology and arrhythmias","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cardiac-amyloidosis","display_name":"cardiac amyloidosis","score":0.8989999890327454},{"id":"https://openalex.org/keywords/transthyretin-stabilizers","display_name":"transthyretin stabilizers","score":0.9330000281333923},{"id":"https://openalex.org/keywords/tafamidis","display_name":"tafamidis","score":0.9819999933242798},{"id":"https://openalex.org/keywords/acoramidis","display_name":"acoramidis","score":0.9480000138282776},{"id":"https://openalex.org/keywords/gender-disparities","display_name":"gender disparities","score":0.7680000066757202},{"id":"https://openalex.org/keywords/racial-and-ethnic-disparities","display_name":"racial and ethnic disparities","score":0.8619999885559082},{"id":"https://openalex.org/keywords/treatment-access","display_name":"treatment access","score":0.48899999260902405},{"id":"https://openalex.org/keywords/attr-act-trial","display_name":"ATTR-ACT trial","score":0.5709999799728394},{"id":"https://openalex.org/keywords/restrictive-cardiomyopathy","display_name":"restrictive cardiomyopathy","score":0.6660000085830688},{"id":"https://openalex.org/keywords/diastolic-dysfunction","display_name":"diastolic dysfunction","score":0.7979999780654907},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.5950000286102295},{"id":"https://openalex.org/keywords/trinetx","display_name":"TriNetX","score":0.6079999804496765},{"id":"https://openalex.org/keywords/electronic-health-records","display_name":"electronic health records","score":0.6930000185966492},{"id":"https://openalex.org/keywords/health-equity","display_name":"health equity","score":0.4869999885559082}],"concepts":[{"id":"https://openalex.org/C121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","level":2,"score":0.9373999834060669},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8003000020980835},{"id":"https://openalex.org/C2777607188","wikidata":"https://www.wikidata.org/wiki/Q5038315","display_name":"Cardiac amyloidosis","level":3,"score":0.6344000101089478},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6331999897956848},{"id":"https://openalex.org/C2779951007","wikidata":"https://www.wikidata.org/wiki/Q816798","display_name":"Amyloidosis","level":2,"score":0.5378000140190125},{"id":"https://openalex.org/C110121322","wikidata":"https://www.wikidata.org/wiki/Q865811","display_name":"Distribution (mathematics)","level":2,"score":0.44429999589920044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.414000004529953},{"id":"https://openalex.org/C2777502316","wikidata":"https://www.wikidata.org/wiki/Q2712515","display_name":"Stabilizer (aeronautics)","level":2,"score":0.38960000872612},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.3637999892234802},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.3199000060558319},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.31459999084472656},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.31349998712539673},{"id":"https://openalex.org/C2994168385","wikidata":"https://www.wikidata.org/wiki/Q6740853","display_name":"Amyloid fibril","level":4,"score":0.2996000051498413},{"id":"https://openalex.org/C81182388","wikidata":"https://www.wikidata.org/wiki/Q353963","display_name":"Complication","level":2,"score":0.2655999958515167}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1016/j.jacadv.2026.103201","doi":"https://doi.org/10.1016/j.jacadv.2026.103201","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103201","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103201?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13699705","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13699705/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13699705/pdf/main.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC Adv","raw_type":"Text"},{"id":"pmid:42910804","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42910804","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC. Advances","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1016/j.jacadv.2026.103201","doi":"https://doi.org/10.1016/j.jacadv.2026.103201","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.jacadv.2026.103201","pdf_url":"https://www.jacc.org/doi/pdf/10.1016/j.jacadv.2026.103201?download=true","source":{"id":"https://openalex.org/S4220651314","display_name":"JACC Advances","issn_l":"2772-963X","issn":["2772-963X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","doyens","jufo-1","ki-jl-1","norway-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JACC: Advances","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7223085277.pdf","grobid_xml":"https://content.openalex.org/works/W7223085277.grobid-xml"},"referenced_works_count":5,"referenced_works":["https://openalex.org/W4388695093","https://openalex.org/W4390690803","https://openalex.org/W4391222670","https://openalex.org/W4392455407","https://openalex.org/W4406463269"],"related_works":["https://openalex.org/W7126380034","https://openalex.org/W3040842159","https://openalex.org/W4409802214","https://openalex.org/W6958502232","https://openalex.org/W7128790422","https://openalex.org/W7133553436","https://openalex.org/W7164016588","https://openalex.org/W4401905391","https://openalex.org/W2889929012","https://openalex.org/W4401389375"],"abstract_inverted_index":{"ransthyretin":[0],"amyloid":[1,14],"cardiomyopathy":[2,49],"(ATTR-CM)":[3],"is":[4,316,342],"characterized":[5],"by":[6,305],"the":[7,17,51,68,82,88,106,169,211,241,285,293,306,317,343],"misfolding,":[8],"deposition,":[9],"and":[10,24,32,100,135,155,161,182,198,216,231,259,353],"accumulation":[11],"of":[12,54,90,103,132,151,195,219,292,308,325],"transthyretin":[13,91,133,225,326],"fibrils":[15],"within":[16],"myocardium.Progressive":[18],"infiltration":[19],"leads":[20],"to":[21,67,129,207,227,233,250,333],"significantly":[22,96,162],"thickened":[23],"rigid":[25],"ventricular":[26,153],"walls,":[27],"diastolic":[28,156],"dysfunction,":[29,157],"conduction":[30],"abnormalities,":[31],"eventually":[33],"heart":[34],"failure.":[35],"1":[36],"This":[37,125],"increasingly":[38],"under-recognized":[39],"condition":[40],"predominantly":[41],"affects":[42],"older":[43],"adults,":[44],"often":[45],"diagnosed":[46],"as":[47,119],"restrictive":[48],"in":[50,76,114,146,165,172,210,214,289,335,349,361],"eighth":[52],"decade":[53],"life.":[55],"2":[56],"Historically,":[57],"median":[58],"survival":[59,99],"for":[60,123],"these":[61],"patients":[62,221,266,339],"has":[63,85],"been":[64],"poor":[65],"due":[66],"limited":[69],"management":[70],"options":[71],"besides":[72],"supportive":[73],"care":[74,270],"and,":[75],"some":[77],"circumstances,":[78],"organ":[79],"transplant.1,2":[80],"Recently,":[81],"therapeutic":[83],"landscape":[84],"evolved":[86],"with":[87,179,224,340],"innovation":[89],"stabilizing":[92],"agents,":[93],"which":[94,188,247],"have":[95],"extended":[97],"patient":[98],"enhanced":[101],"quality":[102],"life.3,4":[104],"Following":[105],"landmark":[107],"ATTR-ACT":[108],"(Transthyretin":[109],"Amyloidosis":[110],"Cardiomyopathy":[111],"Clinical":[112],"Trial)":[113],"2018,":[115],"tafamidis":[116,141],"became":[117],"established":[118],"first":[120],"line":[121],"therapy":[122,178],"ATTR-CM.1,3":[124],"benzoxazole":[126],"derivative":[127],"binds":[128],"thyroxine-binding":[130],"sites":[131],"tetramers":[134],"inhibits":[136],"monomer":[137],"formation.Patients":[138],"who":[139],"received":[140],"experienced":[142],"a":[143,176],"marked":[144,191],"reduction":[145],"all-cause":[147],"mortality,":[148,197,357],"slowed":[149],"progression":[150],"left":[152],"systolic":[154],"decreased":[158],"cardiovascular-related":[159],"hospitalizations,":[160],"lower":[163],"rate":[164],"functional":[166,199],"decline.1,3":[167],"Later,":[168],"ATTRibute-CM":[170],"study":[171,205,300],"2024":[173],"unveiled":[174],"acoramidis,":[175],"novel":[177],"more":[180],"potent":[181],"robust":[183],"(>90%)":[184],"ATTR":[185],"stabilization":[186],"efficacy,":[187],"similarly":[189],"demonstrated":[190],"improvement":[192],"hierarchical":[193],"composite":[194],"morbidity,":[196],"capacity.":[200],"4":[201],"Here,":[202],"our":[203],"database-related":[204],"aims":[206],"provide":[208],"updates":[209],"current":[212,323],"trends":[213],"gender":[215],"racial/ethnic":[217],"distribution":[218],"ATTR-CM":[220,350],"undergoing":[222],"treatment":[223,351],"stabilizers":[226],"promote":[228],"improved":[229],"representation":[230],"access":[232,249],"life-prolonging":[234],"therapies.This":[235],"study's":[236],"data":[237,283],"was":[238,301],"collected":[239],"from":[240,262,267,303],"TriNetX":[242],"United":[243],"States":[244],"Collaborative":[245],"Network,":[246],"provides":[248],"electronic":[251,280],"medical":[252,281],"records":[253],"(diagnoses,":[254],"procedures,":[255],"medications,":[256],"laboratory":[257],"values,":[258],"genomic":[260],"information)":[261],"approximately":[263],"130":[264],"million":[265],"73":[268],"health":[269],"organizations.This":[271],"globally":[272],"federated":[273],"research":[274],"database":[275],"contains":[276],"only":[277],"aggregate,":[278],"deidentified":[279],"record":[282],"per":[284],"deidentification":[286],"standard":[287],"defined":[288],"Section":[290],"\u00a7164.514(a)":[291],"HIPAA":[294],"Privacy":[295],"Rule.Therefore,":[296],"this":[297],"retrospective":[298],"cohort":[299],"exempt":[302],"approval":[304],"University":[307],"Massachusetts":[309],"Medical":[310],"School":[311],"institutional":[312],"review":[313],"board.":[314],"What":[315],"clinical":[318,336],"question":[319],"being":[320],"addressed?How":[321],"do":[322],"patterns":[324],"stabilizer":[327],"use":[328],"across":[329],"demographic":[330],"groups":[331,352],"relate":[332],"disparities":[334],"outcomes":[337],"among":[338],"ATTR-CM?What":[341],"main":[344],"finding?Racial":[345],"minorities":[346],"remain":[347],"under-represented":[348],"experience":[354],"increased":[355],"shortterm":[356],"despite":[358],"no":[359],"difference":[360],"cardiovascular":[362],"events.":[363]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}